首页 > 最新文献

Journal of Yeungnam medical science最新文献

英文 中文
GMNN and DLL1 mutation-related spondylocarpotarsal synostosis: a case report. GMNN和DLL1突变相关的腰椎滑膜闭锁1例报告。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-12-11 DOI: 10.12701/jyms.2024.01137
Joonhwan Lee, Byungju Ryu, Yunhee Kim, Eunyoung Lee

Spondylocarpotarsal synostosis syndrome (SCTS) is a rare genetic disorder characterized by vertebral fusion, short stature, and skeletal anomalies. SCTS is primarily associated with mutations in filamin B. However, in this report, we present a unique case of SCTS in a 28-year-old male who complained of neck and shoulder pain persisting for 1 year. His clinical presentation included radioulnar synostosis, cervical spine anomalies (scoliosis and agenesis of the posterior arch of C1), and a history of polydactyly. Genetic analysis revealed mutations in GMNN and DLL1. To the best of our knowledge, this is the first report on the association of SCTS with these genes.

峡部关节滑脱综合征(SCTS)是一种罕见的遗传性疾病,以椎体融合、身材矮小和骨骼异常为特征。SCTS主要与丝蛋白b突变有关。然而,在本报告中,我们报告了一例独特的SCTS病例,患者为28岁男性,主诉颈部和肩部疼痛持续1年。他的临床表现包括尺桡关节闭锁、颈椎异常(脊柱侧凸和C1后弓发育不全)和多指畸形史。遗传分析显示GMNN和DLL1突变。据我们所知,这是关于SCTS与这些基因关联的第一篇报道。
{"title":"<i>GMNN</i> and <i>DLL1</i> mutation-related spondylocarpotarsal synostosis: a case report.","authors":"Joonhwan Lee, Byungju Ryu, Yunhee Kim, Eunyoung Lee","doi":"10.12701/jyms.2024.01137","DOIUrl":"10.12701/jyms.2024.01137","url":null,"abstract":"<p><p>Spondylocarpotarsal synostosis syndrome (SCTS) is a rare genetic disorder characterized by vertebral fusion, short stature, and skeletal anomalies. SCTS is primarily associated with mutations in filamin B. However, in this report, we present a unique case of SCTS in a 28-year-old male who complained of neck and shoulder pain persisting for 1 year. His clinical presentation included radioulnar synostosis, cervical spine anomalies (scoliosis and agenesis of the posterior arch of C1), and a history of polydactyly. Genetic analysis revealed mutations in GMNN and DLL1. To the best of our knowledge, this is the first report on the association of SCTS with these genes.</p>","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":" ","pages":"15"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of artificial intelligence in managing musculoskeletal pathologies in physiatry: a qualitative observational study evaluating the potential use of ChatGPT versus Copilot for patient information and clinical advice on low back pain. 人工智能在生理肌肉骨骼病理管理中的影响:一项定性观察性研究,评估ChatGPT与Copilot在腰痛患者信息和临床建议方面的潜在应用。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-11-29 DOI: 10.12701/jyms.2024.01151
Christophe Ah-Yan, Ève Boissonnault, Mathieu Boudier-Revéret, Christopher Mares

Background: The self-management of low back pain (LBP) through patient information interventions offers significant benefits in terms of cost, reduced work absenteeism, and overall healthcare utilization. Using a large language model (LLM), such as ChatGPT (OpenAI) or Copilot (Microsoft), could potentially enhance these outcomes further. Thus, it is important to evaluate the LLMs ChatGPT and Copilot in providing medical advice for LBP and assessing the impact of clinical context on the quality of responses.

Methods: This was a qualitative comparative observational study. It was conducted within the Department of Physical Medicine and Rehabilitation, University of Montreal in Montreal, QC, Canada. ChatGPT and Copilot were used to answer 27 common questions related to LBP, with and without a specific clinical context. The responses were evaluated by physiatrists for validity, safety, and usefulness using a 4-point Likert scale (4, most favorable).

Results: Both ChatGPT and Copilot demonstrated good performance across all measures. Validity scores were 3.33 for ChatGPT and 3.18 for Copilot, safety scores were 3.19 for ChatGPT and 3.13 for Copilot, and usefulness scores were 3.60 for ChatGPT and 3.57 for Copilot. The inclusion of clinical context did not significantly change the results.

Conclusion: LLMs, such as ChatGPT and Copilot, can provide reliable medical advice on LBP, irrespective of the detailed clinical context, supporting their potential to aid in patient self-management.

背景:通过患者信息干预对腰痛(LBP)的自我管理在成本、减少缺勤和整体医疗保健利用方面具有显著的好处。使用大型语言模型(LLM),如ChatGPT (OpenAI)或Copilot(微软),可能会进一步增强这些结果。因此,评估LLMs ChatGPT和Copilot在为LBP提供医疗建议和评估临床环境对反应质量的影响方面非常重要。方法:定性比较观察性研究。该研究是在加拿大蒙特利尔的蒙特利尔大学物理医学和康复系进行的。ChatGPT和Copilot用于回答27个与LBP相关的常见问题,无论是否有特定的临床背景。理疗师使用4分李克特量表(4分,最有利)评估这些回答的有效性、安全性和有用性。结果:ChatGPT和Copilot在所有测量中都表现出良好的性能。ChatGPT的效度得分为3.33分,副驾驶为3.18分;ChatGPT的安全性得分为3.19分,副驾驶为3.13分;ChatGPT的有用性得分为3.60分,副驾驶为3.57分。纳入临床背景并没有显著改变结果。结论:无论详细的临床背景如何,ChatGPT和Copilot等llm都可以提供可靠的LBP医疗建议,支持它们帮助患者自我管理的潜力。
{"title":"Impact of artificial intelligence in managing musculoskeletal pathologies in physiatry: a qualitative observational study evaluating the potential use of ChatGPT versus Copilot for patient information and clinical advice on low back pain.","authors":"Christophe Ah-Yan, Ève Boissonnault, Mathieu Boudier-Revéret, Christopher Mares","doi":"10.12701/jyms.2024.01151","DOIUrl":"10.12701/jyms.2024.01151","url":null,"abstract":"<p><strong>Background: </strong>The self-management of low back pain (LBP) through patient information interventions offers significant benefits in terms of cost, reduced work absenteeism, and overall healthcare utilization. Using a large language model (LLM), such as ChatGPT (OpenAI) or Copilot (Microsoft), could potentially enhance these outcomes further. Thus, it is important to evaluate the LLMs ChatGPT and Copilot in providing medical advice for LBP and assessing the impact of clinical context on the quality of responses.</p><p><strong>Methods: </strong>This was a qualitative comparative observational study. It was conducted within the Department of Physical Medicine and Rehabilitation, University of Montreal in Montreal, QC, Canada. ChatGPT and Copilot were used to answer 27 common questions related to LBP, with and without a specific clinical context. The responses were evaluated by physiatrists for validity, safety, and usefulness using a 4-point Likert scale (4, most favorable).</p><p><strong>Results: </strong>Both ChatGPT and Copilot demonstrated good performance across all measures. Validity scores were 3.33 for ChatGPT and 3.18 for Copilot, safety scores were 3.19 for ChatGPT and 3.13 for Copilot, and usefulness scores were 3.60 for ChatGPT and 3.57 for Copilot. The inclusion of clinical context did not significantly change the results.</p><p><strong>Conclusion: </strong>LLMs, such as ChatGPT and Copilot, can provide reliable medical advice on LBP, irrespective of the detailed clinical context, supporting their potential to aid in patient self-management.</p>","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":" ","pages":"11"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital therapeutics in Korea: current status, challenges, and future directions - a narrative review. 韩国的数字疗法:现状、挑战和未来方向 - 综述。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-11-18 DOI: 10.12701/jyms.2024.01004
Hee Jun Shin, Ik Tae Cho, Wan Suk Choi, Hong Rae Kim, Min Bong Kang, Won Jong Yang

Digital therapeutics (DTx) are emerging as a transformative innovation in healthcare offering evidence-based digital interventions for the treatment, management, and prevention of various diseases and disorders. In Korea, DTx have gained significant attention as potential solutions to the increasing burden of chronic diseases and mental health conditions. However, the Korean DTx market faces several challenges that hinder its widespread adoption and integration into the national healthcare system. This study provides a comprehensive analysis of the current state of the DTx market in Korea, identifies the key challenges impeding its growth, and proposes strategies for overcoming these obstacles. This study utilized a literature review and market analysis approach to examine the latest research, industry reports, and regulatory documents related to DTx. The analysis focused on three primary areas: (1) the current regulatory landscape, (2) technological advancements and challenges, and (3) economic and commercial factors influencing DTx adoption in Korea. A comparative analysis of global regulatory practices was also conducted to identify best practices. The findings revealed that while Korea has made significant strides in supporting DTx development, the market remains in its early stages. The key challenges include underdeveloped regulatory frameworks, issues with data quality and security, and a lack of established reimbursement pathways. We recommend developing tailored regulatory frameworks for DTx, enhancing policy support for small and medium-sized enterprises involved in DTx development, and increasing investments in technological infrastructure. By addressing these challenges, Korea could position itself as a leader in the global DTx market, delivering innovative and effective treatments to enhance patient care and outcomes.

数字疗法(DTx)正在成为医疗保健领域的一项变革性创新,为各种疾病和失调的治疗、管理和预防提供基于证据的数字干预措施。在韩国,DTx 作为解决日益加重的慢性病和精神疾病负担的潜在方案,已经获得了极大的关注。然而,韩国 DTx 市场面临着一些挑战,阻碍了其广泛应用和融入国家医疗保健系统。本研究全面分析了韩国 DTx 市场的现状,指出了阻碍其发展的主要挑战,并提出了克服这些障碍的策略。本研究采用文献综述和市场分析的方法,对与 DTx 相关的最新研究、行业报告和监管文件进行了研究。分析主要集中在三个方面:(1) 当前的监管环境;(2) 技术进步与挑战;(3) 影响 DTx 在韩国应用的经济和商业因素。此外,还对全球监管实践进行了比较分析,以确定最佳实践。研究结果表明,虽然韩国在支持 DTx 发展方面取得了长足进步,但该市场仍处于早期阶段。主要挑战包括监管框架不完善、数据质量和安全性问题以及缺乏成熟的报销途径。我们建议为 DTx 制定量身定制的监管框架,加强对参与 DTx 开发的中小型企业的政策支持,并增加对技术基础设施的投资。通过应对这些挑战,韩国可将自己定位为全球 DTx 市场的领导者,提供创新有效的治疗方法,改善患者护理和治疗效果。
{"title":"Digital therapeutics in Korea: current status, challenges, and future directions - a narrative review.","authors":"Hee Jun Shin, Ik Tae Cho, Wan Suk Choi, Hong Rae Kim, Min Bong Kang, Won Jong Yang","doi":"10.12701/jyms.2024.01004","DOIUrl":"10.12701/jyms.2024.01004","url":null,"abstract":"<p><p>Digital therapeutics (DTx) are emerging as a transformative innovation in healthcare offering evidence-based digital interventions for the treatment, management, and prevention of various diseases and disorders. In Korea, DTx have gained significant attention as potential solutions to the increasing burden of chronic diseases and mental health conditions. However, the Korean DTx market faces several challenges that hinder its widespread adoption and integration into the national healthcare system. This study provides a comprehensive analysis of the current state of the DTx market in Korea, identifies the key challenges impeding its growth, and proposes strategies for overcoming these obstacles. This study utilized a literature review and market analysis approach to examine the latest research, industry reports, and regulatory documents related to DTx. The analysis focused on three primary areas: (1) the current regulatory landscape, (2) technological advancements and challenges, and (3) economic and commercial factors influencing DTx adoption in Korea. A comparative analysis of global regulatory practices was also conducted to identify best practices. The findings revealed that while Korea has made significant strides in supporting DTx development, the market remains in its early stages. The key challenges include underdeveloped regulatory frameworks, issues with data quality and security, and a lack of established reimbursement pathways. We recommend developing tailored regulatory frameworks for DTx, enhancing policy support for small and medium-sized enterprises involved in DTx development, and increasing investments in technological infrastructure. By addressing these challenges, Korea could position itself as a leader in the global DTx market, delivering innovative and effective treatments to enhance patient care and outcomes.</p>","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":" ","pages":"8"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unilateral lower extremity lymphedema followed by COVID-19 vaccination in patients with cervical cancer history: two case reports. 宫颈癌史患者单侧下肢淋巴水肿后接种COVID-19: 2例报告
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-01-21 DOI: 10.12701/jyms.2025.42.23
Jae Ik Jung, Hee Kyung Cho

The coronavirus disease 2019 (COVID-19) pandemic prompted the development of messenger RNA vaccines. Following extensive vaccination campaigns worldwide, several adverse reactions to these vaccines have been reported. This is a case series of unilateral lower extremity lymphedema after COVID-19 vaccination in two patients with a history of cervical cancer. An 82-year-old woman and a 68-year-old woman visited the outpatient clinic with unilateral leg edema after receiving a COVID-19 booster vaccine (BNT162b2; Pfizer-BioNTech) in the deltoid muscle. Both patients had a common history of cervical cancer treated with surgery, chemotherapy, and radiotherapy and were in complete remission. Gynecological evaluations, including laboratory and imaging studies, revealed no specific findings. Lymphoscintigraphy revealed delayed lymphatic drainage with diffuse dermal backflow in a unilateral lower extremity. This case series explores adverse reactions to COVID-19 vaccination in patients who are at high risk of developing lymphedema, providing novel data for similar clinical presentations.

2019冠状病毒病(COVID-19)大流行推动了信使RNA疫苗的开发。在全世界广泛开展疫苗接种运动之后,已报告了对这些疫苗的一些不良反应。这是两例有宫颈癌史的患者在接种COVID-19疫苗后出现单侧下肢淋巴水肿的病例系列。一名82岁女性和一名68岁女性在接种了COVID-19加强疫苗(BNT162b2;辉瑞- biontech)在三角肌中的作用。两例患者均有宫颈癌的共同病史,均接受过手术、化疗和放疗,均完全缓解。妇科评估,包括实验室和影像学检查,没有显示出具体的发现。淋巴显像显示单侧下肢延迟淋巴引流伴弥漫性真皮回流。本病例系列探讨了发生淋巴水肿高风险患者对COVID-19疫苗接种的不良反应,为类似的临床表现提供了新的数据。
{"title":"Unilateral lower extremity lymphedema followed by COVID-19 vaccination in patients with cervical cancer history: two case reports.","authors":"Jae Ik Jung, Hee Kyung Cho","doi":"10.12701/jyms.2025.42.23","DOIUrl":"10.12701/jyms.2025.42.23","url":null,"abstract":"<p><p>The coronavirus disease 2019 (COVID-19) pandemic prompted the development of messenger RNA vaccines. Following extensive vaccination campaigns worldwide, several adverse reactions to these vaccines have been reported. This is a case series of unilateral lower extremity lymphedema after COVID-19 vaccination in two patients with a history of cervical cancer. An 82-year-old woman and a 68-year-old woman visited the outpatient clinic with unilateral leg edema after receiving a COVID-19 booster vaccine (BNT162b2; Pfizer-BioNTech) in the deltoid muscle. Both patients had a common history of cervical cancer treated with surgery, chemotherapy, and radiotherapy and were in complete remission. Gynecological evaluations, including laboratory and imaging studies, revealed no specific findings. Lymphoscintigraphy revealed delayed lymphatic drainage with diffuse dermal backflow in a unilateral lower extremity. This case series explores adverse reactions to COVID-19 vaccination in patients who are at high risk of developing lymphedema, providing novel data for similar clinical presentations.</p>","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":"42 ","pages":"23"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143017316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital auscultation in clear and present threat of novel respiratory infectious disease: a narrative review. 数字听诊在新型呼吸道传染病的明确和当前威胁:叙述回顾。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.12701/jyms.2025.42.19
Heeeon Lee, Gun Kim, Jacob Sangwoon Bae

The coronavirus disease 2019 pandemic has underscored the limitations of traditional diagnostic methods, particularly in ensuring the safety of healthcare workers and patients during infectious outbreaks. Smartphone-based digital stethoscopes enhanced with artificial intelligence (AI) have emerged as potential tools for addressing these challenges by enabling remote, efficient, and accessible auscultation. Despite advancements, most existing systems depend on additional hardware and external processing, increasing costs and complicating deployment. This review examines the feasibility and limitations of smartphone-based digital stethoscopes powered by AI, focusing on their ability to perform real-time analyses of audible and inaudible sound frequencies. We also explore the regulatory barriers, data storage challenges, and diagnostic accuracy issues that must be addressed to facilitate broader adoption. The implementation of these devices in veterinary medicine is discussed as a practical step toward refining their applications. With targeted improvements and careful consideration of existing limitations, smartphone-based AI stethoscopes could enhance diagnostic capabilities in human and animal healthcare settings.

2019年冠状病毒病大流行凸显了传统诊断方法的局限性,特别是在传染病暴发期间确保医护人员和患者安全方面的局限性。人工智能(AI)增强的基于智能手机的数字听诊器已经成为解决这些挑战的潜在工具,可以实现远程、高效和可访问的听诊。尽管取得了进步,但大多数现有系统依赖于额外的硬件和外部处理,这增加了成本并使部署复杂化。本文研究了人工智能驱动的基于智能手机的数字听诊器的可行性和局限性,重点关注它们对可听和不可听声音频率进行实时分析的能力。我们还探讨了必须解决的监管障碍、数据存储挑战和诊断准确性问题,以促进更广泛的采用。讨论这些装置在兽医学中的实施,作为改进其应用的实际步骤。通过有针对性的改进和仔细考虑现有的局限性,基于智能手机的人工智能听诊器可以增强人类和动物医疗保健环境中的诊断能力。
{"title":"Digital auscultation in clear and present threat of novel respiratory infectious disease: a narrative review.","authors":"Heeeon Lee, Gun Kim, Jacob Sangwoon Bae","doi":"10.12701/jyms.2025.42.19","DOIUrl":"10.12701/jyms.2025.42.19","url":null,"abstract":"<p><p>The coronavirus disease 2019 pandemic has underscored the limitations of traditional diagnostic methods, particularly in ensuring the safety of healthcare workers and patients during infectious outbreaks. Smartphone-based digital stethoscopes enhanced with artificial intelligence (AI) have emerged as potential tools for addressing these challenges by enabling remote, efficient, and accessible auscultation. Despite advancements, most existing systems depend on additional hardware and external processing, increasing costs and complicating deployment. This review examines the feasibility and limitations of smartphone-based digital stethoscopes powered by AI, focusing on their ability to perform real-time analyses of audible and inaudible sound frequencies. We also explore the regulatory barriers, data storage challenges, and diagnostic accuracy issues that must be addressed to facilitate broader adoption. The implementation of these devices in veterinary medicine is discussed as a practical step toward refining their applications. With targeted improvements and careful consideration of existing limitations, smartphone-based AI stethoscopes could enhance diagnostic capabilities in human and animal healthcare settings.</p>","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":" ","pages":"19"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances and utility of digital twins in critical care and acute care medicine: a narrative review. 数字孪生在重症监护和急症监护医学中的进展和实用性:叙述性综述。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-11-25 DOI: 10.12701/jyms.2024.01053
Gabriele A Halpern, Marko Nemet, Diksha M Gowda, Oguz Kilickaya, Amos Lal

Artificial intelligence (AI) has shown promise for revolutionizing healthcare. This narrative review focuses on the evolving discussion of the utility of AI and clinical informatics in critical care and acute care medicine, specifically focusing on digital twin (DT) technology. The improved computational power and iterative validation of these intelligent tools have enhanced medical education, in silico research, and clinical decision support in critical care settings. Integrating DTs into critical care opens vast opportunities, but simultaneously poses complex challenges, from data safety and privacy concerns to potentially increasing healthcare disparities. In medicine, DTs can significantly improve the efficiency of critical care systems. Stakeholder investment is essential for successful implementation and integration of these technologies.

人工智能(AI)为医疗保健的变革带来了希望。这篇叙述性综述重点讨论了人工智能和临床信息学在重症监护和急症监护医学中的应用,尤其关注数字孪生(DT)技术。这些智能工具计算能力的提高和反复验证增强了重症监护环境中的医学教育、硅学研究和临床决策支持。将数字孪生技术整合到重症监护中带来了巨大的机遇,但同时也带来了复杂的挑战,从数据安全和隐私问题到可能增加的医疗差距。在医学方面,DTs 可以大大提高重症监护系统的效率。利益相关者的投资对于这些技术的成功实施和整合至关重要。
{"title":"Advances and utility of digital twins in critical care and acute care medicine: a narrative review.","authors":"Gabriele A Halpern, Marko Nemet, Diksha M Gowda, Oguz Kilickaya, Amos Lal","doi":"10.12701/jyms.2024.01053","DOIUrl":"10.12701/jyms.2024.01053","url":null,"abstract":"<p><p>Artificial intelligence (AI) has shown promise for revolutionizing healthcare. This narrative review focuses on the evolving discussion of the utility of AI and clinical informatics in critical care and acute care medicine, specifically focusing on digital twin (DT) technology. The improved computational power and iterative validation of these intelligent tools have enhanced medical education, in silico research, and clinical decision support in critical care settings. Integrating DTs into critical care opens vast opportunities, but simultaneously poses complex challenges, from data safety and privacy concerns to potentially increasing healthcare disparities. In medicine, DTs can significantly improve the efficiency of critical care systems. Stakeholder investment is essential for successful implementation and integration of these technologies.</p>","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":" ","pages":"9"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Galectin-3 as a possible link between periodontitis and chronic kidney disease: a cross-sectional study. 半乳糖凝集素-3作为牙周炎和慢性肾脏疾病之间的可能联系:一项横断面研究
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-01-20 DOI: 10.12701/jyms.2025.42.22
Sri Vidhya Marimuthu, Devi Arul, Muthukumar Santhanakrishnan, Ramprasad Elumalai, Sandhya Suresh, Sathya Selvarajan, Ravindranath Dhulipalla, Ramanarayana Boyapati

Background: Chronic periodontitis is associated with various systemic inflammatory diseases; however, research on its association with chronic kidney disease (CKD) is relatively limited. Because both conditions share common risk factors, systemic inflammation plays a key role in the progression of these diseases. Galectin-3 (Gal-3) is a proinflammatory cytokine that plays an important role in chronic inflammatory diseases and is a potential biomarker. This study aimed to measure salivary Gal-3 levels in patients with periodontitis and CKD to better understand their association and evaluate Gal-3 as a diagnostic biomarker for these conditions.

Methods: Seventy-five patients were categorized into three groups: Group I, patients with CKD and periodontitis (n=25); Group II, patients with chronic periodontitis who were systemically healthy (n=25); and Group III, patients with CKD without chronic periodontitis (n=25). Demographic characteristics and periodontal and renal parameters were recorded for each patient. Saliva samples were collected to evaluate Gal-3 levels using an enzyme-linked immunosorbent assay.

Results: Patients with chronic periodontitis and CKD and those with chronic periodontitis alone (Groups I and II, respectively) showed significantly higher salivary Gal-3 levels than patients with CKD alone (Group III) (p<0.001). Bivariate correlation analysis indicated a strong relationship between clinical parameters and Gal-3 levels across all three groups.

Conclusion: Salivary Gal-3 level is a valuable early diagnostic marker of chronic periodontitis and CKD.

背景:慢性牙周炎与多种全身性炎症疾病有关;然而,其与慢性肾脏疾病(CKD)相关性的研究相对有限。由于这两种疾病具有共同的危险因素,因此全身性炎症在这些疾病的进展中起着关键作用。半乳糖凝集素-3 (Galectin-3, Gal-3)是一种促炎细胞因子,在慢性炎症性疾病中发挥重要作用,是一种潜在的生物标志物。本研究旨在测量牙周炎和CKD患者唾液Gal-3水平,以更好地了解它们之间的关联,并评估Gal-3作为这些疾病的诊断性生物标志物。方法:75例患者分为三组:第一组,CKD合并牙周炎患者(n=25);第二组:全身健康的慢性牙周炎患者(n=25);第三组为无慢性牙周炎的CKD患者(n=25)。记录每位患者的人口学特征、牙周和肾脏参数。收集唾液样本,使用酶联免疫吸附法评估Gal-3水平。结果:慢性牙周炎合并慢性牙周炎患者和单独慢性牙周炎患者(分别为I组和II组)的唾液Gal-3水平明显高于单独慢性牙周炎患者(III组)(p结论:唾液Gal-3水平是慢性牙周炎合并慢性牙周炎早期诊断的重要指标。
{"title":"Galectin-3 as a possible link between periodontitis and chronic kidney disease: a cross-sectional study.","authors":"Sri Vidhya Marimuthu, Devi Arul, Muthukumar Santhanakrishnan, Ramprasad Elumalai, Sandhya Suresh, Sathya Selvarajan, Ravindranath Dhulipalla, Ramanarayana Boyapati","doi":"10.12701/jyms.2025.42.22","DOIUrl":"10.12701/jyms.2025.42.22","url":null,"abstract":"<p><strong>Background: </strong>Chronic periodontitis is associated with various systemic inflammatory diseases; however, research on its association with chronic kidney disease (CKD) is relatively limited. Because both conditions share common risk factors, systemic inflammation plays a key role in the progression of these diseases. Galectin-3 (Gal-3) is a proinflammatory cytokine that plays an important role in chronic inflammatory diseases and is a potential biomarker. This study aimed to measure salivary Gal-3 levels in patients with periodontitis and CKD to better understand their association and evaluate Gal-3 as a diagnostic biomarker for these conditions.</p><p><strong>Methods: </strong>Seventy-five patients were categorized into three groups: Group I, patients with CKD and periodontitis (n=25); Group II, patients with chronic periodontitis who were systemically healthy (n=25); and Group III, patients with CKD without chronic periodontitis (n=25). Demographic characteristics and periodontal and renal parameters were recorded for each patient. Saliva samples were collected to evaluate Gal-3 levels using an enzyme-linked immunosorbent assay.</p><p><strong>Results: </strong>Patients with chronic periodontitis and CKD and those with chronic periodontitis alone (Groups I and II, respectively) showed significantly higher salivary Gal-3 levels than patients with CKD alone (Group III) (p<0.001). Bivariate correlation analysis indicated a strong relationship between clinical parameters and Gal-3 levels across all three groups.</p><p><strong>Conclusion: </strong>Salivary Gal-3 level is a valuable early diagnostic marker of chronic periodontitis and CKD.</p>","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":"42 ","pages":"22"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143017807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 30-year-old male patient who experienced recurring weakness in bilateral upper and lower extremities: a clinical vignette.
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-02-17 DOI: 10.12701/jyms.2025.42.27
Soo Hyun Ahn, Mathieu Boudier-Revéret, Seoyon Yang, Min Cheol Chang
{"title":"A 30-year-old male patient who experienced recurring weakness in bilateral upper and lower extremities: a clinical vignette.","authors":"Soo Hyun Ahn, Mathieu Boudier-Revéret, Seoyon Yang, Min Cheol Chang","doi":"10.12701/jyms.2025.42.27","DOIUrl":"https://doi.org/10.12701/jyms.2025.42.27","url":null,"abstract":"","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":"42 ","pages":"27"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-specific predictors of successful frozen embryo transfer using the freeze-all protocol: a retrospective observational study.
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-02-25 DOI: 10.12701/jyms.2025.42.28
Hyun Joo Lee, Eun Hee Yu, Jong Kil Joo

Background: The aim of this study was to examine various patient factors affecting first programmed embryo transfer (ET) outcomes under the freeze-all policy at a single tertiary university infertility center.

Methods: This retrospective observational study reviewed the medical records of 243 couples who underwent their first ET using blastocysts collected under the freeze-all antagonist-controlled ovarian stimulation (COS) protocol from 2015 to 2023. Patients were grouped into pregnant and nonpregnant groups, and their data, including demographics, COS and ET outcomes, and embryo storage duration, were analyzed.

Results: Patient body mass index, cause of infertility, follicle-to-oocyte index, distribution of blastocyst grades, number of transferred embryos, and embryo storage duration were not significantly different between the groups. In a simple comparative analysis, patients with successful clinical pregnancy tended to have significantly lower female and male age (33.83±3.67 and 35.32±4.54 years vs. 37.07±4.15 and 39.33±5.60 years, respectively), higher anti-Müllerian hormone levels (6.27±5.32 ng/mL vs. 4.14±3.82 ng/mL) and antral follicle counts (14.20±8.26 vs. 10.04±5.75), and higher numbers of retrieved oocytes and metaphase II oocytes (13.74±6.92 and 9.64±6.19 vs. 11.21±6.04 and 7.53±5.56, respectively). Multivariate logistic regression analysis of these variables revealed that only male age was a significant factor for successful clinical pregnancy (odds ratio, 4.768; 95% confidence interval, 1.252-18.162; p=0.022).

Conclusion: During the first programmed ET using blastocysts collected under the freeze-all antagonist COS protocol, male age and correspondingly the quality of gametes for fertilization were crucial for successful pregnancy, having more importance than calculated female ovarian reserve and embryo storage duration.

{"title":"Patient-specific predictors of successful frozen embryo transfer using the freeze-all protocol: a retrospective observational study.","authors":"Hyun Joo Lee, Eun Hee Yu, Jong Kil Joo","doi":"10.12701/jyms.2025.42.28","DOIUrl":"https://doi.org/10.12701/jyms.2025.42.28","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to examine various patient factors affecting first programmed embryo transfer (ET) outcomes under the freeze-all policy at a single tertiary university infertility center.</p><p><strong>Methods: </strong>This retrospective observational study reviewed the medical records of 243 couples who underwent their first ET using blastocysts collected under the freeze-all antagonist-controlled ovarian stimulation (COS) protocol from 2015 to 2023. Patients were grouped into pregnant and nonpregnant groups, and their data, including demographics, COS and ET outcomes, and embryo storage duration, were analyzed.</p><p><strong>Results: </strong>Patient body mass index, cause of infertility, follicle-to-oocyte index, distribution of blastocyst grades, number of transferred embryos, and embryo storage duration were not significantly different between the groups. In a simple comparative analysis, patients with successful clinical pregnancy tended to have significantly lower female and male age (33.83±3.67 and 35.32±4.54 years vs. 37.07±4.15 and 39.33±5.60 years, respectively), higher anti-Müllerian hormone levels (6.27±5.32 ng/mL vs. 4.14±3.82 ng/mL) and antral follicle counts (14.20±8.26 vs. 10.04±5.75), and higher numbers of retrieved oocytes and metaphase II oocytes (13.74±6.92 and 9.64±6.19 vs. 11.21±6.04 and 7.53±5.56, respectively). Multivariate logistic regression analysis of these variables revealed that only male age was a significant factor for successful clinical pregnancy (odds ratio, 4.768; 95% confidence interval, 1.252-18.162; p=0.022).</p><p><strong>Conclusion: </strong>During the first programmed ET using blastocysts collected under the freeze-all antagonist COS protocol, male age and correspondingly the quality of gametes for fertilization were crucial for successful pregnancy, having more importance than calculated female ovarian reserve and embryo storage duration.</p>","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":"42 ","pages":"28"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143494992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in hepatocellular carcinoma: hepatocarcinogenesis, role of exosomal noncoding RNAs, and diagnostic pathology. 肝细胞癌研究进展:肝癌发生、外泌体非编码 RNA 的作用以及病理诊断。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-11-07 DOI: 10.12701/jyms.2024.01221
Joon Hyuk Choi
{"title":"Advances in hepatocellular carcinoma: hepatocarcinogenesis, role of exosomal noncoding RNAs, and diagnostic pathology.","authors":"Joon Hyuk Choi","doi":"10.12701/jyms.2024.01221","DOIUrl":"10.12701/jyms.2024.01221","url":null,"abstract":"","PeriodicalId":74020,"journal":{"name":"Journal of Yeungnam medical science","volume":" ","pages":"2"},"PeriodicalIF":1.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Yeungnam medical science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1